23852717|t|In vitro investigation of amyloid-beta hepatobiliary disposition in sandwich-cultured primary rat hepatocytes.
23852717|a|Failure in amyloid-beta (Abeta) systemic clearance across the liver has been suggested to play a role in Abeta brain accumulation and thus to contribute largely to the pathology of Alzheimer's disease (AD). The purpose of this study was to characterize in vitro the transport mechanisms of Abeta40 across the liver using sandwich-cultured primary rat hepatocytes (SCHs) and to determine its biliary clearance (CL(bile)) and biliary excretion index (BEI%). 125I-Abeta40 BEI% was time dependent and reached steady state at 30 minutes, with an average value of 29.8% and a CL(bile) of 1.47 ml/min per kilogram of body weight. The role of low-density lipoprotein receptor-related protein-1 (LRP1) in mediating the basolateral uptake of 125I-Abeta40 in SCHs was assessed using receptor-associated protein (RAP, 2 microM). A significant reduction in 125I-Abeta40 BEI% and CL(bile) with RAP was observed, demonstrating a major contribution of LRP1 in mediating hepatic uptake of intact 125I-Abeta40 via transcytosis. Furthermore, activity studies suggested a lower role of receptor for advanced glycation end products (RAGE) in 125I-Abeta40 hepatic uptake. Verapamil (50 microM) and valspodar (20 microM) significantly reduced 125I-Abeta40 BEI%, indicating a role for P-glycoprotein (P-gp) in the biliary excretion of 125I-Abeta40 in SCHs. LRP1- and P-gp-mediated 125I-Abeta40 biliary excretion was inducible and increased BEI% by 26% after rifampicin pretreatment. In conclusion, our findings demonstrated that besides LRP1, P-gp and, to a lesser extent, RAGE are involved in 125I-Abeta40 hepatobiliary disposition and support the use of enhancement of Abeta hepatic clearance via LRP1 and P-gp induction as a novel therapeutic approach for the prevention and treatment of AD.
23852717	94	97	rat	Species	10116
23852717	136	141	Abeta	Gene	54226
23852717	216	221	Abeta	Gene	54226
23852717	292	311	Alzheimer's disease	Disease	MESH:D000544
23852717	313	315	AD	Disease	MESH:D000544
23852717	458	461	rat	Species	10116
23852717	567	571	125I	Chemical	MESH:C000614960
23852717	746	796	low-density lipoprotein receptor-related protein-1	Gene	299858
23852717	798	802	LRP1	Gene	299858
23852717	843	847	125I	Chemical	MESH:C000614960
23852717	912	915	RAP	Chemical	-
23852717	955	959	125I	Chemical	MESH:C000614960
23852717	991	994	RAP	Chemical	-
23852717	1047	1051	LRP1	Gene	299858
23852717	1090	1094	125I	Chemical	MESH:C000614960
23852717	1177	1221	receptor for advanced glycation end products	Gene	81722
23852717	1223	1227	RAGE	Gene	81722
23852717	1232	1236	125I	Chemical	MESH:C000614960
23852717	1261	1270	Verapamil	Chemical	MESH:D014700
23852717	1287	1296	valspodar	Chemical	MESH:C070272
23852717	1331	1335	125I	Chemical	MESH:C000614960
23852717	1372	1386	P-glycoprotein	Gene	24646
23852717	1388	1392	P-gp	Gene	24646
23852717	1422	1426	125I	Chemical	MESH:C000614960
23852717	1444	1448	LRP1	Gene	299858
23852717	1454	1458	P-gp	Gene	24646
23852717	1468	1472	125I	Chemical	MESH:C000614960
23852717	1545	1555	rifampicin	Chemical	MESH:D012293
23852717	1624	1628	LRP1	Gene	299858
23852717	1630	1634	P-gp	Gene	24646
23852717	1660	1664	RAGE	Gene	81722
23852717	1681	1685	125I	Chemical	MESH:C000614960
23852717	1758	1763	Abeta	Gene	54226
23852717	1786	1790	LRP1	Gene	299858
23852717	1795	1799	P-gp	Gene	24646
23852717	1878	1880	AD	Disease	MESH:D000544
23852717	Association	MESH:C000614960	81722
23852717	Association	MESH:C000614960	24646
23852717	Association	299858	54226
23852717	Association	MESH:C000614960	299858
23852717	Negative_Correlation	MESH:C000614960	MESH:C070272
23852717	Positive_Correlation	MESH:D012293	299858
23852717	Association	MESH:D000544	24646
23852717	Negative_Correlation	MESH:C000614960	MESH:D014700
23852717	Association	MESH:D000544	54226
23852717	Positive_Correlation	MESH:D012293	24646
23852717	Association	24646	54226

